Jeffrey Viveiros, NP
Family · East Greenwich, RINPI 1740666932
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,009 of the $3,039 with a category attached, or 66.1%. 16 manufacturers reported payments, led by EPI Health, LLC at 25.5% of the total. Reporting peaked in 2022 at $1,254 and has fallen 60.9% since, to $490 in 2025.
Across 76 payments — averaging $39.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EPI Health, LLC$776
- Johnson & Johnson$479
- AbbVie$344
- Novartis$275
- Galderma Laboratories, L.p.$245
- Pfizer$220
- plus $701 from 10 others
What the payments were for
- Consulting fees$75025%
- Food & beverage$2,00966%
- Education$2809%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EPI Health, LLC | 7 | $776 |
| Johnson & Johnson | 14 | $479 |
| AbbVie | 17 | $344 |
| Novartis | 5 | $275 |
| Galderma Laboratories, L.p. | 5 | $245 |
| Pfizer | 11 | $220 |
| Incyte Corporation | 6 | $180 |
| Sun Pharmaceutical Industries Inc. | 1 | $125 |
| Amgen | 1 | $102 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
| Sanofi | 1 | $55 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $48 |
| Strata Skin Sciences, Inc. | 3 | $33 |
| LEO Pharma Inc. | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Dermavant Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,039 in reported general payments places this provider in the 85th percentile of 457 family providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 161 | $9,167 |
| Clobetasol Propionate | 112 | $5,647 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 11 | $5,583 |
| Ketoconazole | 148 | $2,910 |
| Betamethasone Dipropionate | 40 | $1,738 |
| Azelaic Acid | 13 | $1,347 |
| Doxycycline Hyclate | 46 | $1,146 |
| Triamcinolone Acetonide | 88 | $930 |
| Metronidazole | 21 | $773 |
| Econazole Nitrate | 14 | $615 |
| Desonide | 18 | $567 |
| Minoxidil | 60 | $519 |
| Ciclopirox | 15 | $416 |
| Mometasone Furoate | 17 | $374 |
| Doxycycline Monohydrate | 13 | $242 |
Paid to pharmacies, not to this prescriber.
Other family in East Greenwich
- Patricia SchmidtEast Greenwich$7K
- Karen RuggEast Greenwich$4K
- Amber DepaolaEast Greenwich$3K
- Samantha CapeceEast Greenwich$2K
- Carol RobinsonWarwick$82K
- Mark ClarkeSmithfield$37K
- Olga FedorenkoCoventry$24K
- Alicia VatterWarwick$15K
- Kaleigh RapozaJohnston$14K
- David RamosRiverside$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.